These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
179 related articles for article (PubMed ID: 17932492)
1. Proteins, drug targets and the mechanisms they control: the simple truth about complex networks. Araujo RP; Liotta LA; Petricoin EF Nat Rev Drug Discov; 2007 Nov; 6(11):871-80. PubMed ID: 17932492 [TBL] [Abstract][Full Text] [Related]
2. Drug targets for tumorigenesis: insights from structural analysis of EGFR signaling network. Durmuş Tekir S; Yalçin Arga K; Ulgen KO J Biomed Inform; 2009 Apr; 42(2):228-36. PubMed ID: 18790083 [TBL] [Abstract][Full Text] [Related]
3. Molecular-targeted therapies: lessons from years of clinical development. Rosa DD; Ismael G; Lago LD; Awada A Cancer Treat Rev; 2008 Feb; 34(1):61-80. PubMed ID: 17826917 [TBL] [Abstract][Full Text] [Related]
4. Livin/ML-IAP as a new target for cancer treatment. Liu B; Han M; Wen JK; Wang L Cancer Lett; 2007 Jun; 250(2):168-76. PubMed ID: 17218055 [TBL] [Abstract][Full Text] [Related]
6. [Molecular-targeted therapy for malignant glioma]. Yamanaka R Brain Nerve; 2009 Feb; 61(2):177-88. PubMed ID: 19235468 [TBL] [Abstract][Full Text] [Related]
7. Multitargeted therapy: can promiscuity be praised in an era of political correctness? Jimeno A; Hidalgo M Crit Rev Oncol Hematol; 2006 Aug; 59(2):150-8. PubMed ID: 16843676 [TBL] [Abstract][Full Text] [Related]
8. Apoptotic blocks and chemotherapy resistance: strategies to identify Bcl-2 protein signatures. Gul O; Basaga H; Kutuk O Brief Funct Genomic Proteomic; 2008 Jan; 7(1):27-34. PubMed ID: 18283052 [TBL] [Abstract][Full Text] [Related]
9. Drug resistance in cancer - searching for mechanisms, markers and therapeutic agents. O'Connor R; Clynes M; Dowling P; O'Donovan N; O'Driscoll L Expert Opin Drug Metab Toxicol; 2007 Dec; 3(6):805-17. PubMed ID: 18028026 [TBL] [Abstract][Full Text] [Related]
10. Therapeutic targeting of apoptosis pathways in cancer. Ziegler DS; Kung AL Curr Opin Oncol; 2008 Jan; 20(1):97-103. PubMed ID: 18043263 [TBL] [Abstract][Full Text] [Related]
12. Reverse phase protein microarrays for theranostics and patient-tailored therapy. Espina V; Wulfkuhle J; Calvert VS; Liotta LA; Petricoin EF Methods Mol Biol; 2008; 441():113-28. PubMed ID: 18370315 [TBL] [Abstract][Full Text] [Related]
13. Targeting the EGFR and the PKB pathway in cancer. Klein S; Levitzki A Curr Opin Cell Biol; 2009 Apr; 21(2):185-93. PubMed ID: 19216065 [TBL] [Abstract][Full Text] [Related]
15. Somatic pharmacogenomics in cancer. Ikediobi ON Pharmacogenomics J; 2008 Oct; 8(5):305-14. PubMed ID: 18679398 [TBL] [Abstract][Full Text] [Related]
16. [Drug resistance mediated by survival- and growth-promoting signaling pathways]. Fujita N Gan To Kagaku Ryoho; 2009 Apr; 36(4):567-71. PubMed ID: 19381028 [TBL] [Abstract][Full Text] [Related]
17. [mTOR signal pathway and its inhibitors in antitumor therapy: a review]. Huang JJ; Lin TY Ai Zheng; 2007 Dec; 26(12):1397-403. PubMed ID: 18076811 [TBL] [Abstract][Full Text] [Related]
18. Therapeutic protein kinase inhibitors. Grant SK Cell Mol Life Sci; 2009 Apr; 66(7):1163-77. PubMed ID: 19011754 [TBL] [Abstract][Full Text] [Related]
19. Cancer chemoprevention and chemotherapy: dietary polyphenols and signalling pathways. Ramos S Mol Nutr Food Res; 2008 May; 52(5):507-26. PubMed ID: 18435439 [TBL] [Abstract][Full Text] [Related]
20. From protein interaction networks to novel therapeutic strategies. Jaeger S; Aloy P IUBMB Life; 2012 Jun; 64(6):529-37. PubMed ID: 22573601 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]